Leukemia Research
Volume 28, Issue 8 , Pages 821-829 , August 2004

Inhibition of acute myeloid leukemia cell growth by mono-specific and bi-specific anti-CD33 × anti-CD64 antibodies

  • Larisa Balaian
    • ,
  • Edward D Ball

      Affiliations

    • Corresponding Author InformationCorresponding author. Present address: Blood and Marrow Transplantation Division, University of California San Diego, 9500 Gilman Drive, La Jolla, CA 92093-0960, USA. Tel.: +1-858-657-7053; fax: +1-858-657-6837.

Received 29 July 2003 ,Accepted 2 December 2003.

References 

  1. Griffin JD, Linch D, Sabbath K, Larcom P, Schlossman SF. A monoclonal antibody reactive with normal and leukemic human myeloid progenitor cells. Leuk. Res. 1984;8:521–534
  2. Ball ED, McDermott, Griffin JD, Davey FR, Davis R, Bloomfield CD. Expression of the three myeloid cell-associated immunoglobulin G Fc receptors defined by murine monoclonal antibodies on normal bone marrow and acute leukemia cells. Blood 1989;73:1951–6.
  3. Ball ED. Immunophenotyping of acute myeloid leukemia cells. Clin. Lab. Med. 1990;110:721–736
  4. Applebaum FR. Antibody-targeted therapy for myeloid leukemia. Semin. Hematol. 1999;36:2–8
  5. Fanger MW, Morganelli PM, Guyre PM. Bispecific antibodies. Crit. Rev. Immunol. 1992;12:101–124
  6. Chen J, Zhou JH, Ball ED. Monocyte-mediated lysis of acute myeloid leukemia cells in the presence of the bispecific antibody 251×22 (anti-CD33 x anti-CD64). Clin. Cancer Res. 1995;1:1319–1325
  7. Glennie MJ, McBride HM, Worth AT, Stevenson GT. Preparation and performance of bispecific F(ab′ gamma) 2 antibody containing thioether linked Fab′ gamma fragments. J. Immunol. 1987;139:2365–2367
  8. Ball ED, Guyre PM, Mills L, Fisher J, Dinces NB, Fanger MW. Initial trial of bispecific antibody-mediated immunotherapy of CD15-bearing tumors: cytotoxicity of human tumor cells using a bispecific antibody comprised of anti-CD15 (MoAb PM81) and anti-CD64/Fc-gamma RI (MoAb32). J. Hematother. 1992;1:85–94
  9. Silla LM, Chen J, Zhong RK, Whiteside TM, Ball ED. Potentiation of lysis of leukemia cells by a bispecific antibody to CD33 and CD16 (Fc gamma RIII) expressed by human natural killer (NK) cells. Br. J. Haematol. 1995;89:712–718
  10. Balaian L, Ball ED. Direct effect of bi-specific anti-CD33 x anti-CD64 antibody on proliferation and signaling in myeloid cells. Leuk. Res. 2001;25:1115–1125
  11. Duchemin AM, Ernst LK, Anderson CL. Clustering of the high affinity Fc receptor for immunoglobulin G (Fc gamma RI) results in phosphorylation of its associated gamma chain. J. Biol. Chem. 1994;269:12111–12117
  12. Indik ZK, Park JG, Hunter S, Schreiber AD. The molecular dissection of Fc gamma receptor mediated phagocytosis. Blood. 1995;86:4389–4399
  13. Wang AV, Scholl PR, Geha RS. Physical and functional association of the high affinity immunoglobulin G receptor (Fc gamma RI) with the kinases Hck and Lyn. J. Exp. Med. 1994;180:1165–1170
  14. Pan XQ, Darby C, Indik ZK, Schreiber AD. Activation of three classes of nonreceptor tyrosine kinases following Fc gamma receptor crosslinking in human monocytes. Clin. Immunol. 1999;90:55–64
  15. Kiener PA, Rankin BM, Burkhardt AL, Shieven GL, Gilliard LK, Rowley RB, et al.  Cross-linking of Fc gamma receptor I (Fc gamma RI) and receptor II (Fc gamma RII) on monocytic cells activated a signal transduction pathway common to both Fc receptors that involves the stimulation of p72 Syk protein tyrosine kinase. J. Biol. Chem. 1993;268:24442–24448
  16. Taylor A, Jahn T, Smith S, Lamkin T, Uribe L, Liu J, et al.  Differential activation of the tyrosine kinases ZAP-70 and Syk after Fc gamma RI stimulation. Blood. 1997;87:388–396
  17. Cambier JC. Antigen and Fc receptor signaling. The awesome power of the immunoreceptor tyrosine-based activation motif (ITAM). J. Immunol. 1995;155:3281–3285
  18. Ulyanova T, Blasioli J, Woodford-Thomas TA, Thomas ML. The sialoadhesin CD33 is a myeloid-specific inhibitory receptor. Eur. J. Immunol. 1999;29:3440–3449
  19. Taylor VC, Buckley CD, Douglas M, Cody AJ, Simmons DL, Freeman SD. The myeloid-specific sialic acid-binding receptor, CD33, associates with the protein tyrosine phosphatases, SHP-1 and SHP-2. J. Biol. Chem. 1999;274:11505–11512
  20. Paul SP, Taylor LS, Stansbury EK, McVicar DW. Myeloid specific human CD33 is an inhibitory receptor with differential ITIM function in recruiting the phosphatases SHP-1 and SHP-2. Blood. 2000;96:483–488
  21. Darzynkiewicz Z, Gong G, Traganos F. Analysis of DNA content and cyclic protein expression in studies of DNA ploidy, growth fraction, lymphocyte stimulating and the cell cycle Flow Cytometry. Methods Cell Biol. 1994;141:421–435
  22. Vitale C, Romagnani C, Falco M, Ponte M, Mingari MC. Engagement of p75/AIRM-1 or CD33 inhibits the proliferation of normal or leukemic myeloid cells. PNAS. 1999;96:15091–15096
  23. Vitale C, Romagnani C, Puccetti A, Olive D, Mingari MC. Surface expression and function of p75/AIRM-1 or CD33 in acute myeloid leukemias: Engagement of CD33 induces apoptosis of leukemic cells. PNAS. 2001;98:5764–5769
  24. Mingari MC, Vitale C, Romagnani C, Falco M, Moretta L. p75/AIRM-1 and CD33, two sialoadhesin receptors that regulate proliferation or the survival of normal and leukemic myeloid cells. Immunol. Rev. 2001;181:260–268
  25. Neppert J, Jungi TW. Antibodies to human major histocompatibility complex products inhibit Fc gamma receptors types I and II. Transus. Med. 1996;2:125–131
  26. Warmerdam PA, van den Herik-Oudijk IE, Parren PW, Westerdaal NA, van de Winkel JG, Capel PJ. Interaction of a human Fc gamma RIIb1 (CD32) isoform with murine and human IgG subclasses. Int. Immunol. 1993;3:239–247
  27. Balaian L, Zhong RK, Ball ED. The inhibitory effect of anti-CD33 monoclonal antibodies on AML cell growth correlates with Syk and/or ZAP-70 expression. Exp. Hematol. 2003;31:363–371
  28. Marcilla A, Rivero-Lezcano OM, Agarwal A, Robbins KC. Identification of the major tyrosine kinase substrate in signaling complexes formed after engagement of Fc gamma receptor. J. Biol. Chem. 1995;270:9115–9120
  29. Brizzi MF, Rosso A, Dentelli P, Ferrero D, Lanfancne L, Pegoraro L. C-Cbl tyrosine phosphorylation and subcellular localization in human primary leukemia cells. Exp. Hematol. 1998;26:1228–1239

PII: S0145-2126(03)00412-0

doi: 10.1016/j.leukres.2003.12.001

Leukemia Research
Volume 28, Issue 8 , Pages 821-829 , August 2004

Article Tools

* Image Usage & Resolution